Dataset Information

Predicting proteome dynamics using gene expression data.

ABSTRACT: While protein concentrations are physiologically most relevant, measuring them globally is challenging. mRNA levels are easier to measure genome-wide and hence are typically used to infer the corresponding protein abundances. The steady-state condition (assumption that protein levels remain constant) has typically been used to calculate protein concentrations, as it is mathematically convenient, even though it is often not satisfied. Here, we propose a method to estimate genome-wide protein abundances without this assumption. Instead, we assume that the system returns to its baseline at the end of the experiment, which is true for cyclic phenomena (e.g. cell cycle) and many time-course experiments. Our approach only requires availability of gene expression and protein half-life data. As proof-of-concept, we predicted proteome dynamics associated with the budding yeast cell cycle, the results are available for browsing online at http://dynprot.cent.uw.edu.pl/ . The approach was validated experimentally by verifying that the predicted protein concentration changes were consistent with measurements for all proteins tested. Additionally, if proteomic data are available as well, we can also infer changes in protein half-lives in response to posttranslational regulation, as we did for Clb2, a post-translationally regulated protein. The predicted changes in Clb2 abundance are consistent with earlier observations.

SUBMITTER: Kuchta K

PROVIDER: S-EPMC6138643 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Predicting proteome dynamics using gene expression data.

Kuchta Krzysztof K Towpik Joanna J Biernacka Anna A Kutner Jan J Kudlicki Andrzej A Ginalski Krzysztof K Rowicka Maga M

Scientific reports 20180914 1

While protein concentrations are physiologically most relevant, measuring them globally is challenging. mRNA levels are easier to measure genome-wide and hence are typically used to infer the corresponding protein abundances. The steady-state condition (assumption that protein levels remain constant) has typically been used to calculate protein concentrations, as it is mathematically convenient, even though it is often not satisfied. Here, we propose a method to estimate genome-wide protein abun ...[more]

PMID: 30217992

Similar Datasets

Project description:BackgroundOne of the current directions of precision medicine is the use of computational methods to aid in the diagnosis, prognosis, and treatment of disease based on data driven approaches. For instance, in oncology, there has been a particular focus on development of algorithms and biomarkers that can be used for pre-clinical and clinical applications. In particular large-scale omics-based models to predict drug sensitivity in in vitro cancer cell line panels have been used to explore the utility and aid in the development of these models as clinical tools. Additionally, a number of web-based interfaces have been constructed for researchers to explore the potential of drug perturbed gene expression as biomarkers including the NCI Transcriptional Pharmacodynamic Workbench. In this paper we explore the influence of drug perturbed gene dynamics of the NCI Transcriptional Pharmacodynamics Workbench in computational models to predict in vitro drug sensitivity for 15 drugs on the NCI60 cell line panel.ResultsThis work presents three main findings. First, our models show that gene expression profiles that capture changes in gene expression after 24 h of exposure to a high concentration of drug generates the most accurate predictive models compared to the expression profiles under different dosing conditions. Second, signatures of 100 genes are developed for different gene expression profiles; furthermore, when the gene signatures are applied across gene expression profiles model performance is substantially decreased when gene signatures developed using changes in gene expression are applied to non-drugged gene expression. Lastly, we show that the gene interaction networks developed on these signatures show different network topologies and can be used to inform selection of cancer relevant genes.ConclusionOur models suggest that perturbed gene signatures are predictive of drug response, but cannot be applied to predict drug response using unperturbed gene expression. Furthermore, additional drug perturbed gene expression measurements in in vitro cell lines could generate more predictive models; but, more importantly be used in conjunction with computational methods to discover important drug disease relationships.

Project description:Background The study of gene essentiality, which measures the importance of a gene for cell division and survival, is used for the identification of cancer drug targets and understanding of tissue-specific manifestation of genetic conditions. In this work, we analyze essentiality and gene expression data from over 900 cancer lines from the DepMap project to create predictive models of gene essentiality. Methods We developed machine learning algorithms to identify those genes whose essentiality levels are explained by the expression of a small set of “modifier genes”. To identify these gene sets, we developed an ensemble of statistical tests capturing linear and non-linear dependencies. We trained several regression models predicting the essentiality of each target gene, and used an automated model selection procedure to identify the optimal model and hyperparameters. Overall, we examined linear models, gradient boosted trees, Gaussian process regression models, and deep learning networks. Results We identified nearly 3000 genes for which we accurately predict essentiality using gene expression data of a small set of modifier genes. We show that both in the number of genes we successfully make predictions for, as well as in the prediction accuracy, our model outperforms current state-of-the-art works. Conclusions Our modeling framework avoids overfitting by identifying the small set of modifier genes, which are of clinical and genetic importance, and ignores the expression of noisy and irrelevant genes. Doing so improves the accuracy of essentiality prediction in various conditions and provides interpretable models. Overall, we present an accurate computational approach, as well as interpretable modeling of essentiality in a wide range of cellular conditions, thus contributing to a better understanding of the molecular mechanisms that govern tissue-specific effects of genetic disease and cancer. Supplementary Information The online version contains supplementary material available at 10.1186/s12920-023-01446-6.

Project description:Carcinogenesis is a complex process with multiple genetic and environmental factors contributing to the development of one or more tumors. Understanding the underlying mechanism of this process and identifying related markers to assess the outcome of this process would lead to more directed treatment and thus significantly reduce the mortality rate of cancers. Recently, molecular diagnostics and prognostics based on the identification of patterns within gene expression profiles in the context of protein interaction networks were reported. However, the predictive performances of these approaches were limited. In this study we propose a novel integrated approach, named CAERUS, for the identification of gene signatures to predict cancer outcomes based on the domain interaction network in human proteome. We first developed a model to score each protein by quantifying the domain connections to its interacting partners and the somatic mutations present in the domain. We then defined proteins as gene signatures if their scores were above a preset threshold. Next, for each gene signature, we quantified the correlation of the expression levels between this gene signature and its neighboring proteins. The results of the quantification in each patient were then used to predict cancer outcome by a modified naïve Bayes classifier. In this study we achieved a favorable accuracy of 88.3%, sensitivity of 87.2%, and specificity of 88.9% on a set of well-documented gene expression profiles of 253 consecutive breast cancer patients with different outcomes. We also compiled a list of cancer-associated gene signatures and domains, which provided testable hypotheses for further experimental investigation. Our approach proved successful on different independent breast cancer data sets as well as an ovarian cancer data set. This study constitutes the first predictive method to classify cancer outcomes based on the relationship between the domain organization and protein network.

Dataset Information

Predicting proteome dynamics using gene expression data.

Publications

Predicting proteome dynamics using gene expression data.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets